UQCRHP2

Across TCGA pan-cancer cohorts, UQCRHP2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of UQCRHP2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where UQCRHP2 RNA is repressed in tumor relative to normal tissue. In most cancer types UQCRHP2 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, LUAD, and LIHC are the cancer types where UQCRHP2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UQCRHP2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−0.097	.003	3	view →
LUAD	Female	II,III,IV	+0.209	.020	2	view →
LIHC	All	All	+0.072	.033	2	view →
THCA	Female	All	−0.102	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

UQCRHP2–KIRC

Open the KIRC breakdown →